In vitro models of important MAC functions such as migration and angiogenesis, offer an opportunity to investigate novel vasculoprotective agents, including vitamin D. In the context of SLE, MACs are dysfunctional due, in part, to effects of interferon-alpha (IFNα)7, 8. The gene discussed is IFNA2; the disease is systemic lupus erythematosus.